|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-3-8
|
|
pubmed:abstractText |
Hepatitis C recurring after liver transplant may cause progressive liver dysfunction, and available treatment regimens are unsatisfactory. A better understanding of the mechanisms of action of drugs currently used to manage hepatitis C would be helpful.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
373-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11884933-Adult,
pubmed-meshheading:11884933-Antiviral Agents,
pubmed-meshheading:11884933-Cytokines,
pubmed-meshheading:11884933-Female,
pubmed-meshheading:11884933-Hepatitis C,
pubmed-meshheading:11884933-Humans,
pubmed-meshheading:11884933-Liver,
pubmed-meshheading:11884933-Liver Transplantation,
pubmed-meshheading:11884933-Male,
pubmed-meshheading:11884933-Middle Aged,
pubmed-meshheading:11884933-RNA, Messenger,
pubmed-meshheading:11884933-RNA, Viral,
pubmed-meshheading:11884933-Ribavirin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.
|
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, University Hospital, 1211 Geneva, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
